Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?
PLoS MedicinePublished 19 September 2007Open access
Sergio Sismondo
Citations252
SJR quartileQ1
SJR score4.28
SNIP3.21
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Sismondo discusses how pharmaceutical companies and their agents shape multiple steps in the research, analysis, writing, and publication of articles.
Abstract
Sismondo discusses how pharmaceutical companies and their agents shape multiple steps in the research, analysis, writing, and publication of articles.
Keywords
Social SciencesEconomics, Econometrics and FinancePharmacology, Toxicology and Pharmaceutics
BMJPharmaceutical industry sponsorship and research outcome and quality: systematic review
2,163 Citations2003Joel Lexchin, Lisa A Bero +2 more
Investigating whether funding of drug studies by the pharmaceutical industry is associated with outcomes that are favourable to the funder and whether the methods of trials funded by pharmaceutical companies differ from the methods in trials with other sources of support found systematic bias favours products which are made by the company funding the research.
JAMAScope and Impact of Financial Conflicts of Interest in Biomedical Research
1,803 Citations2003Justin E. Bekelman, Yan Li +1 more
Original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research are reviewed to show a statistically significant association between industry sponsorship and pro-industry conclusions.
New England Journal of MedicineUneasy Alliance — Clinical Investigators and the Pharmaceutical Industry
771 Citations2000Thomas Bodenheimer
The past 10 years have seen the spectacular growth of a new research model, and commercially oriented networks of contract-research organizations (CROs) and site-management organizations (SMOs) have altered.
JAMAWithholding Research Results in Academic Life Science
583 Citations1997David Blumenthal
Withholding of research results is not a widespread phenomenon among life-science researchers, however, withholding is more common among the most productive and entrepreneurial faculty.
JAMAWhen authorship fails. A proposal to make contributors accountable
572 Citations1997Drummond Rennie
JAMAPrevalence of Articles With Honorary Authors and Ghost Authors in Peer-Reviewed Medical Journals
550 Citations1998Annette Flanagin
A substantial proportion of articles in peer-reviewed medical journals demonstrate evidence of honorary authors or ghost authors.
Human RelationsValues and Organizational Structure
448 Citations1996C. R. Hinings, Lucie Thibault +2 more
Cochrane Database of Systematic ReviewsEditorial peer review for improving the quality of reports of biomedical studies
310 Citations2007Tom Jefferson, Melanie Rudin +2 more
Little empirical evidence is available to support the use of editorial peer review as a mechanism to ensure quality of biomedical research and a large, well-funded programme of research on the effects of editorialpeer review should be urgently launched.
PLoS MedicineGhost Authorship in Industry-Initiated Randomised Trials
286 Citations2007Peter C Gøtzsche, Asbjørn Hróbjartsson +4 more
Ghost authorship in industry-initiated trials is very common and its prevalence could be considerably reduced, and transparency improved, if existing guidelines were followed, and if protocols were publicly available.
Social Studies of ScienceThe Contract Research Organization and the Commercialization of Scientific Research
260 Citations2005Philip Mirowski, Robert Van Horn
The contract research organization (CRO) warrants wider attention as a modern paradigm of privatized science in the biopharmaceutical sector and the wider implications of the modern regime of commercialized science for the future conduct of scientific research are confronted.
JAMAPrevalence of Honorary and Ghost Authorship in Cochrane Reviews
229 Citations2002G Mowatt
A substantial proportion of reviews had evidence of honorary and ghost authorship, and the Cochrane editorial teams contributed to most Cochrane reviews.
The British Journal of PsychiatryInterface between authorship, industry and science in the domain of therapeutics
218 Citations2003David Healy, Dinah Cattell
The emerging style of authorship in industry-linked articles can deliver good-quality articles, but it raises concerns for the scientific base of therapeutics, and the literature profiles and citation rates of industry- linked and non-industry- linked articles differ.
Science CommunicationPeer Review for Journals as it Stands Today—Part 1
200 Citations1998Juan Miguel Campanario
It is difficult to imagine how science could advance without such a key quality control mechanism as peer review, the author concludes.
JAMAMultiple Authorship
180 Citations1998Joost P.H. Drenth
Over the last 20 years the number of BMJ authors of original articles increased, mainly because of the rise of authorship among professors and department chairpersons.
Journal of Medical EthicsBiomedical conflicts of interest: a defence of the sequestration thesis—learning from the cases of Nancy Olivieri and David Healy
154 Citations2004A Schafer
After a literature survey of the ways in which corporate sponsorship has biased the results of clinical drug trials, two different strategies to mitigate this problem are identified and assessed: a regulatory approach, which focuses on managing risks associated with industry funding of university research, and a more radical approach, the sequestration thesis, which counsels the outright elimination of corporate sponsorship.
New England Journal of MedicineAcademic Medical Centers' Standards for Clinical-Trial Agreements with Industry
136 Citations2005Michelle M. Mello, Brian Clarridge +1 more
Standards for certain restrictive provisions in clinical-trial agreements with industry sponsors vary considerably among academic medical centers, and greater sharing of information about legal relationships with industry sponsor is desirable to build consensus about appropriate standards.
Science CommunicationPeer Review for Journals as it Stands Today—Part 2
134 Citations1998Juan Miguel Campanario
Social Studies of ScienceShaping the Intimate:
130 Citations2004David Healy
A series of mechanisms whereby company marketing can both transform the perceptions of physicians and shape the experiences of those seeking treatment and the self-understanding of those not in treatment are reviewed.
Perspectives in biology and medicineGhost Marketing: Pharmaceutical Companies and Ghostwritten Journal Articles
125 Citations2007Barton Moffatt, Carl Elliott
This article focuses on the type of ghostwriting that involves a pharmaceutical company hiring a medical education and communications company to write a paper favorable of their product and then hires a well-known academic to publish it under his or her name without disclosing the paper's true origins.
PLoS BiologyA New Trade Framework for Global Healthcare R&D
110 Citations2004Tim Hubbard, James Love
Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them and it is time to explore some alternatives, Hubbard and Love contend.
The Hastings Center ReportPharma Goes to the Laundry: Public Relations and the Business of Medical Education
77 Citations2004Carl Elliott
By laundering its message through the MECCS, pharma gives up some control, but the pay-off is even better: advertisements with the appearance of objectivity.
Accountability in ResearchHaunted Manuscripts: Ghost Authorship in the Medical Literature
74 Citations2005Stephanie Ngai, Jennifer Gold +2 more
This work states that evidence-based medicine requires that clinical decisions be based on empirical evidence published in peer-reviewed medical journals, and if physicians base their decisions on dubious research data, this can have negative consequences for patients.
American PsychologistPsychology in the Prescription Era: Building a Firewall Between Marketing and Science.
65 Citations2003David O. Antonuccio, William G. Danton +1 more
To preserve the integrity of psychological science, the authors propose an aspirational "firewall" designed to separate industry marketing from the science of psychology.
Journal of General Internal MedicineThe corporate coauthor
59 Citations2005Adriane Fugh‐Berman
Conflicts of interest may be difficult to detect in the subset of articles and presentations sponsored by pharmaceutical companies that never mention the targeted drug, but focus on stimulating the perceived need for the targetedDrug or highlighting problems with competing drugs.
Annals of PharmacotherapyImplications of Pharmaceutical Industry Funding on Clinical Research
54 Citations2004Joel Lexchin
It is difficult to obtain funding from some sources for research with limited commercial value and lack of communication among researchers can impede scientific progress, according to the influence of industry funding.
Journal of Continuing Education in the Health ProfessionsMedical education and communication companies: An updated in-depth profile
12 Citations2002Gil A. Golden, Jacqueline Parochka +1 more
Future studies of CME providers should continue to expand the base of knowledge regarding these organizations, resulting in better understanding among all types of providers, opportunities for collaboration, and, ultimately, education that improves patient care.